Peper, J.
Schaap, J.
Kelder, J. C.
Rensing, B. J. W. M.
Grobbee, D. E.
Leiner, T.
Swaans, M. J.
Article History
Received: 11 June 2020
Accepted: 21 January 2021
First Online: 24 March 2021
Competing interests
: Dr. M.J. Swaans reports personal fees from consultancy for Abbott Vascular, Boston Scientific, Philips Healthcare and Bioventrix Inc., outside the submitted work. Prof. Dr. T. Leiner received grants from the Dutch Technology Foundation (P15-26, 12726), with participation of Pie Medical Imaging and Philips Healthcare, from the Netherlands Organisation for Health Research and Development, with participation of Pie Medical Imaging, and from Pie Medical Imaging; holds stock in Quantib-U; is cofounder, scientific lead, and a shareholder at Quantib-U. The other authors declare no competing interests.